(HealthDay) -- Ultraviolet B (UVB) is preferred by dermatologists for first-line treatment of moderate to severe psoriasis in both healthy male and female patients, according to a study published in the March issue of the ...
Feb 24, 2012
0
0
A group of former senior editors, writing in The BMJ today, criticise a "seriously flawed and inflammatory attack" by The New England Journal of Medicine (NEJM) on what that journal believes have become overly stringent policies ...
Jun 3, 2015
0
37
(HealthDay)—Anti-programmed cell death (PD)-1 therapy for metastatic melanoma is associated with the development of immune-related cutaneous events, according to research published in the March issue of the Journal of the ...
Mar 16, 2016
0
3
For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published ...
Mar 18, 2022
0
12
(HealthDay)—An updated universal definition of myocardial infarction (MI) includes detection of a rise and/or fall in cardiac biomarker values, preferably cardiac troponin (cTn), according to a statement published online ...
Aug 28, 2012
0
0
(HealthDay)—Disrupted sleep is associated with increased amyloid-β production in adults, according to a study published online Dec. 8 in the Annals of Neurology.
Dec 13, 2017
0
16
(HealthDay)—In men with complete erectile dysfunction (ED), tadalafil 2.5 and 5 mg once-daily result an in intercourse success rate of 32.4 and 46.4 percent, respectively, according to research published online Oct. 4 in ...
Oct 14, 2012
0
0
For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an increased risk for hypertension, according to a study published in the March issue ...
Mar 21, 2023
0
2
(HealthDay) -- Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC) who ...
Jun 5, 2012
0
0
(HealthDay)—For adult patients with Crohn's disease, adalimumab and infliximab + azathioprine are most effective for induction and maintenance of remission, according to a meta-analysis published in the February issue of ...
Jan 28, 2015
0
6
